Quantcast
Channel: BioSpace.com News
Viewing all articles
Browse latest Browse all 79

FDA Accepts for Review Theravance, Inc.'s Complete Response Submission for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections

0
0

SOUTH SAN FRANCISCO, CA--(Marketwire - April 24, 2009) - Theravance, Inc. (NASDAQ: THRX)announced today that the U.S. Food and Drug Administration (FDA) acceptedas complete for review Theravance's response to the February 2009 CompleteResponse letter, which outlined requirements for approval of telavancin...


Viewing all articles
Browse latest Browse all 79

Latest Images

Trending Articles





Latest Images